Last updated: June 1, 2026
Which companies supply MIOSTAT drug substance and finished product?
No complete, authoritative supplier map can be produced from the information provided.
What is MIOSTAT’s active ingredient and NDA/BLA reference product name?
No complete, authoritative supplier map can be produced without identifying MIOSTAT’s active ingredient and the correct FDA application (NDA/BLA) and reference listed drug (RLD) name.
What are the MIOSTAT Orange Book listings and who holds them?
No complete, authoritative supplier map can be produced without the Orange Book entry for MIOSTAT (RLD name, application number, and listed patent holders).
Are there multiple strengths, dosage forms, or label-licensed suppliers for MIOSTAT?
No complete, authoritative supplier map can be produced without the marketed dosage form(s) and strength(s) for MIOSTAT and their labelholder/manufacturer information.
What contract manufacturing organizations (CMOs) make MIOSTAT for the labeler?
No complete, authoritative supplier map can be produced without access to manufacturer/distributor disclosures tied to the specific FDA label and marketing authorization for MIOSTAT.
Which distributors and wholesalers supply MIOSTAT to hospitals and pharmacies?
No complete, authoritative supplier map can be produced without the specific product label (NDC) and distribution chain tied to MIOSTAT’s marketed presentation.
How does MIOSTAT’s supply chain differ across geographies?
No complete, authoritative supplier map can be produced without country-specific product approvals and label/manufacturer disclosures.
What manufacturing/IP barriers could block new MIOSTAT suppliers?
No complete, authoritative supplier map can be produced without the relevant FDA approval pathways, manufacturing site disclosures, and any associated listed patents governing the marketed presentation.
Key Takeaways
- A supplier answer requires the drug’s exact FDA identity (active ingredient plus NDA/BLA/RLD name) and the specific marketed presentation (dosage form/strength, NDC).
- Supplier roles (label holder vs. manufacturer vs. distributor) must be tied to the Orange Book/FDA label records for MIOSTAT’s specific listing.
FAQs
- What NDC identifies MIOSTAT’s marketed product?
- Who is the labeler of record for MIOSTAT on the FDA label?
- Which sites manufacture MIOSTAT under FDA inspections?
- Is MIOSTAT supplied as a single-source product or via multiple manufacturers?
- Do any Paragraph IV challenges or settlements affect supplier entry timing for MIOSTAT?
References
None.
